Vimarsana
Biggest News Aggregation in the World

Peter Stenvinkel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Stenvinkel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Stenvinkel Today - Breaking & Trending Today

How Can Cardiovascular Risk Be Reduced in Kidney Dialysis? - Vimarsana News

How Can Cardiovascular Risk Be Reduced in Kidney Dialysis?

The experimental IL-6 inhibitor clazakizumab improves key inflammation markers in one study, whereas another shows lower risks with home hemodialysis vs peritoneal dialysis.

Revolution in Age Measurement: Scientists Develop the Most Accurate Biological Aging Test Yet - Vimarsana News

Revolution in Age Measurement: Scientists Develop the Most Accurate Biological Aging Test Yet

A team of European researchers has developed an innovative test that accurately measures biological aging in a clinical setting. The discovery was made while studying patients for the aging effects of chronic kidney disease. The new test is an epigenetic clock – a type of biochemical assessment t

Most accurate test to date developed to measu - Vimarsana News

Most accurate test to date developed to measu

<p><strong>A team of European researchers has developed a new test that can accurately measure biological aging in a clinical setting. The discovery was made while studying patients for the aging effects of chronic kidney disease.</strong></p>

Climate change and women - Los Angeles Times - Vimarsana News

Climate change and women - Los Angeles Times

UCLA cardiologist Barbara Natterson-Horowitz discusses the disproportionate effects of climate change on female animals, including women and girls.

Invizius Announces Appointment of Peter Stenvinkel, Professor of Nephrology at Karolinska Institutet, to the Clinical Advisory Board - Vimarsana News

Invizius Announces Appointment of Peter Stenvinkel, Professor of Nephrology at Karolinska Institutet, to the Clinical Advisory Board

/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing treatments to suppress unwanted immune responses in haemodialysis, is pleased...